Skip to main content
Fig. 3 | BMC Complementary Medicine and Therapies

Fig. 3

From: Combination of Quercetin or/and siRNA-loaded DDAB-mPEG-PCL hybrid nanoparticles reverse resistance to Regorafenib in colon cancer cells

Fig. 3

 A The IC50 values of the Regorafenib group, including free drug (Regorafenib), RDMP, and RDMP/siRNA complex in both resistance and non-resistance cell lines. B The IC50 values of the Quercetin group, including free drug (Quercetin), QDMP, and QDMP/siRNA complex in both resistance and non-resistance cell lines. RDMP: Reg/DDAB mPEG-PCL nanoparticles; QDMP: Q/DDAB mPEG-PCL nanoparticles; siRNA; small interfering RNA

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us